NASDAQ$MASI
Masimo Corp. · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
Reported first quarter 2024 financial results.
Masimo's consolidated revenue was $492.8 million, with healthcare revenue at $339.6 million and non-healthcare revenue at $153.2 million. The company reported a GAAP net income per diluted share of $0.35 and a non-GAAP net income per diluted share of $0.77.
- Consolidated revenue reached $492.8 million.
- Healthcare revenue amounted to $339.6 million.
- Non-healthcare revenue totaled $153.2 million.
- GAAP net income per diluted share was $0.35, while non-GAAP net income per diluted share was $0.77.
Headline financials
Revenue & EPS history
Masimo · Revenue · Quarterly
$493M
Forward guidance
Masimo provided estimates for its second quarter 2024 and updated full-year 2024 guidance.
Tailwinds
- Consolidated revenue is expected to be between $480 million and $510 million for Q2 2024 and between $2,055 million and $2,165 million for the full year 2024.
- Healthcare revenue is projected to be between $330 million and $340 million for Q2 2024 and between $1,355 million and $1,385 million for the full year 2024.
- Non-healthcare revenue is anticipated to be between $150 million and $170 million for Q2 2024 and between $700 million and $780 million for the full year 2024.
- Consolidated operating income is estimated to be between $33 million and $38 million (GAAP) or $67 million and $72 million (Non-GAAP) for Q2 2024.
- Consolidated earnings per diluted share are expected to be between $0.26 and $0.33 (GAAP) or $0.73 and $0.79 (Non-GAAP) for Q2 2024.
Headwinds
- The estimates are based on current expectations and are subject to uncertainties and factors that could cause actual results to differ materially.
- Risks include dependence on Masimo SET® and Masimo rainbow SET™ products, competition, and failure to develop innovative products.
- The guidance is subject to the company's ability to manage cost structure and the pace of recovery in inpatient volumes.
- Potential uncertainty during the pendency of any such potential separation that could affect Masimo’s financial performance
- Negative effects of the announcement or pendency of any such potential separation on the market price of Masimo’s securities and/or on the financial performance of Masimo
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2024
-0.6%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+1.6%
Avg return
30 days after
54%
35 / 65 earnings
Positive
+17.2%
Q2 2024
Best reaction
-35.8%
Q4 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +0.1% | +0.4% | |
| Q4 2025 | +0.1% | +7.4% | +0.6% | |
| Q3 2025 | -4.8% | -3.0% | -4.9% | |
| Q1 2025 | -6.5% | +1.3% | +6.5% | |
| Q4 2024 | +12.3% | +12.4% | -3.5% | |
| Q3 2024 | +13.7% | +10.2% | +14.9% | |
| Q2 2024 | +17.2% | +21.1% | +9.0% | |
| Q1 2024 | -13.0% | -11.8% | -9.6% | |
| Q4 2023 | -1.5% | -3.2% | +12.4% | |
| Q3 2023 | +2.5% | +6.6% | +30.5% | |
| Q2 2023 | -4.1% | -7.6% | -11.8% | |
| Q1 2023 | -7.0% | -8.0% | -16.1% | |
| Q4 2022 | +4.1% | +7.9% | +5.6% | |
| Q3 2022 | -12.1% | +3.1% | +10.1% | |
| Q2 2022 | +2.1% | -0.2% | -0.4% | |
| Q1 2022 | +7.5% | +8.5% | +19.8% | |
| Q4 2021 | -35.8% | -31.3% | -29.9% | |
| Q3 2021 | +1.4% | -0.7% | +0.1% | |
| Q2 2021 | -0.6% | +2.3% | +3.8% | |
| Q1 2021 | -6.9% | -5.5% | -12.4% | |
| Q4 2020 | +0.5% | +0.3% | -9.6% | |
| Q3 2020 | -5.1% | -9.0% | -0.3% | |
| Q2 2020 | -7.2% | -6.6% | -6.7% | |
| Q1 2020 | -0.6% | +1.7% | +9.3% | |
| Q4 2019 | +0.2% | -4.5% | -14.5% | |
| Q3 2019 | -1.5% | -2.2% | +4.7% | |
| Q2 2019 | -2.8% | -7.8% | -3.2% | |
| Q1 2019 | -1.5% | +1.1% | -2.9% | |
| Q4 2018 | +1.3% | +3.9% | +5.5% | |
| Q3 2018 | -2.2% | -3.3% | -4.5% | |
| Q2 2018 | +8.9% | +9.1% | +18.6% | |
| Q1 2018 | +4.3% | +7.6% | +10.2% | |
| Q4 2017 | +2.2% | -1.4% | +2.7% | |
| Q3 2017 | +1.3% | -1.0% | +2.3% | |
| Q2 2017 | -10.3% | -10.8% | -11.5% | |
| Q1 2017 | -14.2% | -17.0% | -12.5% | |
| Q4 2016 | +5.7% | +11.1% | +21.9% | |
| Q3 2016 | +5.5% | +10.7% | +12.3% | |
| Q2 2016 | +9.3% | +6.1% | +14.0% | |
| Q1 2016 | +7.7% | — | — | |
| Q4 2015 | +5.7% | — | — | |
| Q3 2015 | +4.0% | — | — | |
| Q2 2015 | +6.2% | — | — | |
| Q1 2015 | +1.0% | — | — | |
| Q4 2014 | +8.0% | — | — | |
| Q3 2014 | +7.0% | — | — | |
| Q2 2014 | -11.2% | — | — | |
| Q1 2014 | -9.1% | — | — | |
| Q4 2013 | -4.2% | — | — | |
| Q3 2013 | -9.2% | — | — | |
| Q2 2013 | +5.5% | — | — | |
| Q1 2013 | +7.5% | — | — | |
| Q4 2012 | -0.3% | — | — | |
| Q3 2012 | -1.1% | — | — | |
| Q2 2012 | -6.2% | — | — | |
| Q1 2012 | -6.6% | — | — | |
| Q4 2009 | -3.8% | — | — | |
| Q4 2011 | -3.8% | — | — | |
| Q3 2011 | +1.1% | — | — | |
| Q2 2011 | -8.4% | — | — | |
| Q1 2011 | +4.0% | — | — | |
| Q3 2010 | +0.0% | — | — | |
| Q2 2010 | +1.1% | — | — | |
| Q4 2010 | +1.1% | — | — | |
| Q1 2010 | +2.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro